SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-062634
Filing Date
2019-11-12
Accepted
2019-11-12 16:16:41
Documents
3
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1919554d3_8k.htm 8-K 17934
2 EXHIBIT 99.1 tm1919554d3_ex99-1.htm EX-99.1 94712
3 GRAPHIC image_001.jpg GRAPHIC 211029
  Complete submission text file 0001104659-19-062634.txt   404572
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 191209642
SIC: 2834 Pharmaceutical Preparations